News and Trends 21 Aug 2017
German Biotech Starts Trials with a Personalized Cell Therapy for Multiple Cancers
Immatics will start a first clinical trial to test IMA101, a personalized cell therapy with the potential to treat multiple types of solid tumors. Based in Tübingen, Germany, Immatics has announced today the start of its first clinical trial testing its cell therapy technology aimed at providing personalized treatments for multiple types of solid tumors. The […]